Browse by all authors Browse By Author Name - Scott,+MA

Browse Results (5 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Gandhi, MK, Jestice, HK, Scott, MA, Bloxham, DM, Bass, G, Craig, JIO and Marcus, RE (1999) A comparison of CD34(+) cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis. Bone Marrow Transplantation, 24 4: 369-375. doi:10.1038/sj.bmt.1701938 26   17 0
Baxter, EJ, Scott, LM, Campbell, PJ, East, C, Fourouclas, N, Swanton, S, Vassiliou, GS, Bench, AJ, Boyd, EM, Curtin, N, Scott, MA, Erber, WN and Green, AR (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365 9464: 1054-1061. doi:10.1016/S0140-6736(05)71142-9 73   1601 Cited 1761 times in Scopus1761 6
Scott, MA, Gandhi, MK, Jestice, HK, Mahendra, P, Bass, G and Marcus, RE (1998) A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Bone Marrow Transplantation, 22 3: 273-276. doi:10.1038/sj.bmt.1701327 15   42 0
Campbell, PJ, Scott, LM, Buck, G, Wheatley, K, East, CL, Marsden, JT, Duffy, A, Boyd, EM, Bench, AJ, Scott, MA, Vassiliou, GS, Milligan, DW, Smith, SR, Erber, WN, Bareford, D, Wilkins, BS, Reilly, JT, Harrison, CN and Green, AR (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 366 9501: 1945-1953. doi:10.1016/S0140-6736(05)67785-9 19   374 Cited 426 times in Scopus426 3
Gandhi, MK, Jestice, K, Scott, MA, Bloxham, D, Bass, G and Marcus, RE (1999) The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplantation, 23 1: 9-13. doi:10.1038/sj.bmt.1701530 29   47 0